Medicine guide

Lanreotide Acetate

90 mg/.3mL · Injection

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupHeart, blood pressure and circulation

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Made by	Cipla USA Inc.
Active substance	Lanreotide Acetate
Used in	Heart, blood pressure and circulation
Strength	90 mg/.3mL
Form	Injection
Route	Subcutaneous
Packs	1 SYRINGE in 1 CARTON / .3 mL in 1 SYRINGE · 1 POUCH in 1 CARTON / 1 SYRINGE in 1 POUCH / .3 mL in 1 SYRINGE
NDC	69097-890
NDC	69097-908

Source: NDC Directory · 2026-09-13 · not reviewed by a clinician

Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).

6 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Injection6 products
- 60 mg/.2mL2
  60 mg/.2mL · 2 companies
  - Cipla USA Inc.
  - EXELAN PHARMACEUTICALS, INC.
- 90 mg/.3mL2
  90 mg/.3mL · 2 companies
  - Cipla USA Inc. · this page
  - EXELAN PHARMACEUTICALS, INC.
- 120 mg/.5mL2
  120 mg/.5mL · 2 companies
  - Cipla USA Inc.
  - EXELAN PHARMACEUTICALS, INC.

These contain the same substance. That does not mean one can replace another — ask a pharmacist.